1. Home
  2. TDW vs IBRX Comparison

TDW vs IBRX Comparison

Compare TDW & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

HOLD

Current Price

$57.67

Market Cap

2.7B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$2.31

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDW
IBRX
Founded
1956
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TDW
IBRX
Price
$57.67
$2.31
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$67.50
$9.83
AVG Volume (30 Days)
936.3K
10.5M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.97
N/A
Revenue
$1,361,073,000.00
$82,555,000.00
Revenue This Year
$0.76
$667.18
Revenue Next Year
$0.81
$88.32
P/E Ratio
$19.42
N/A
Revenue Growth
4.42
1025.95
52 Week Low
$31.17
$1.83
52 Week High
$64.07
$5.12

Technical Indicators

Market Signals
Indicator
TDW
IBRX
Relative Strength Index (RSI) 57.12 53.74
Support Level $53.38 $2.06
Resistance Level $55.36 $2.34
Average True Range (ATR) 2.83 0.15
MACD 0.38 0.03
Stochastic Oscillator 73.19 64.13

Price Performance

Historical Comparison
TDW
IBRX

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: